Plain-English translation of NCT06410274 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study is investigating what happens to blood flow in the brain after a bleeding stroke (intracerebral haemorrhage). Researchers want to understand why lowering blood pressure—which is currently standard care—doesn't always prevent death or disability, and whether it might accidentally reduce blood flow to healthy parts of the brain.
Current guidelines recommend lowering blood pressure after a bleeding stroke, but large studies haven't shown this actually reduces death or disability. Doctors need to understand whether the medication or treatment is inadvertently causing new problems by reducing blood flow to areas of the brain that are still healthy.
You likely qualify if…
You likely don't qualify if…
You will have brain imaging scans and monitoring of your brain's blood flow and blood pressure at two time points: within 48 hours of your stroke and again 3–7 days later. This is an observation study, meaning researchers will monitor you but won't give you any new medications or treatments—they'll simply track what happens naturally as you receive standard care.
AI-generated summary from trial data · Jul 19, 2026 · Not medical advice
United Kingdom
Collaborators
University Hospitals, Leicester
Enrollment target
~120 participants
Started
June 2024
Primary completion
January 2029
Age range
18 Years – 120 Years
Last updated on clinicaltrials.gov in September 2024.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Jatinder Minhas, SFHEA
University of Leicester
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.